CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands |
Total |
Lilly |
Common Stock [Member] |
Common Stock [Member]
Lilly
|
Additional Paid-In Capital [Member] |
Additional Paid-In Capital [Member]
Lilly
|
Accumulated Deficit [Member] |
Accumulated Deficit [Member]
Lilly
|
Accumulated Other Comprehensive Income (Loss) [Member] |
Accumulated Other Comprehensive Income (Loss) [Member]
Lilly
|
Beginning balance at Dec. 31, 2019 |
$ 131,300
|
|
$ 2,918
|
|
$ 441,395
|
|
$ (314,599)
|
|
$ 1,586
|
|
Beginning balance, shares at Dec. 31, 2019 |
|
|
28,882,217
|
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
602
|
|
$ 13
|
|
589
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
127,205
|
|
|
|
|
|
|
|
Stock-based compensation |
2,291
|
|
|
|
2,291
|
|
|
|
|
|
Currency translation adjustment |
(3,107)
|
|
|
|
|
|
|
|
(3,107)
|
|
Net loss |
(16,500)
|
|
|
|
|
|
(16,500)
|
|
|
|
Ending balance at Mar. 31, 2020 |
114,586
|
|
$ 2,931
|
|
444,275
|
|
(331,099)
|
|
(1,521)
|
|
Ending balance, shares at Mar. 31, 2020 |
|
|
29,009,422
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2019 |
131,300
|
|
$ 2,918
|
|
441,395
|
|
(314,599)
|
|
1,586
|
|
Beginning balance, shares at Dec. 31, 2019 |
|
|
28,882,217
|
|
|
|
|
|
|
|
Short-swing profit disgorgement |
0
|
|
|
|
|
|
|
|
|
|
Currency translation adjustment |
3,508
|
|
|
|
|
|
|
|
|
|
Net loss |
(57,549)
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2020 |
84,501
|
|
$ 2,938
|
|
448,617
|
|
(372,148)
|
|
5,094
|
|
Ending balance, shares at Sep. 30, 2020 |
|
|
29,074,536
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2020 |
114,586
|
|
$ 2,931
|
|
444,275
|
|
(331,099)
|
|
(1,521)
|
|
Beginning balance, shares at Mar. 31, 2020 |
|
|
29,009,422
|
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
291
|
|
$ 4
|
|
287
|
|
0
|
|
0
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
37,922
|
|
|
|
|
|
|
|
Stock-based compensation |
1,192
|
|
$ 0
|
|
1,192
|
|
0
|
|
0
|
|
Currency translation adjustment |
2,201
|
|
0
|
|
0
|
|
0
|
|
2,201
|
|
Net loss |
(17,974)
|
|
0
|
|
0
|
|
(17,974)
|
|
0
|
|
Ending balance at Jun. 30, 2020 |
100,296
|
|
$ 2,935
|
|
445,754
|
|
(349,073)
|
|
680
|
|
Ending balance, shares at Jun. 30, 2020 |
|
|
29,047,344
|
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
22
|
|
$ 3
|
|
19
|
|
0
|
|
0
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
27,192
|
|
|
|
|
|
|
|
Stock-based compensation |
2,844
|
|
$ 0
|
|
2,844
|
|
0
|
|
0
|
|
Currency translation adjustment |
4,414
|
|
0
|
|
0
|
|
0
|
|
4,414
|
|
Net loss |
(23,075)
|
|
0
|
|
0
|
|
(23,075)
|
|
0
|
|
Ending balance at Sep. 30, 2020 |
84,501
|
|
$ 2,938
|
|
448,617
|
|
(372,148)
|
|
5,094
|
|
Ending balance, shares at Sep. 30, 2020 |
|
|
29,074,536
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
102,263
|
|
$ 3,211
|
|
490,093
|
|
(400,112)
|
|
9,071
|
|
Beginning balance, shares at Dec. 31, 2020 |
|
|
31,602,953
|
|
|
|
|
|
|
|
Issuance of common stock |
129,403
|
$ 16,477
|
$ 610
|
$ 77
|
128,793
|
$ 16,400
|
|
$ 0
|
|
$ 0
|
Issuance of common stock, shares |
|
|
5,575,757
|
706,834
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
4,824
|
|
$ 42
|
|
4,782
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
386,097
|
|
|
|
|
|
|
|
Repurchase of restricted stock units |
(285)
|
|
|
|
(285)
|
|
|
|
|
|
Stock-based compensation |
3,400
|
|
|
|
3,400
|
|
|
|
|
|
Currency translation adjustment |
(9,391)
|
|
|
|
|
|
|
|
(9,391)
|
|
Net loss |
(10,154)
|
|
|
|
|
|
(10,154)
|
|
|
|
Ending balance at Mar. 31, 2021 |
236,537
|
|
$ 3,940
|
|
643,183
|
|
(410,266)
|
|
(320)
|
|
Ending balance, shares at Mar. 31, 2021 |
|
|
38,271,641
|
|
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
102,263
|
|
$ 3,211
|
|
490,093
|
|
(400,112)
|
|
9,071
|
|
Beginning balance, shares at Dec. 31, 2020 |
|
|
31,602,953
|
|
|
|
|
|
|
|
Short-swing profit disgorgement |
(282)
|
|
|
|
|
|
|
|
|
|
Currency translation adjustment |
(11,307)
|
|
|
|
|
|
|
|
|
|
Net loss |
(52,395)
|
|
|
|
|
|
|
|
|
|
Ending balance at Sep. 30, 2021 |
205,769
|
|
$ 3,976
|
|
656,536
|
|
(452,507)
|
|
(2,236)
|
|
Ending balance, shares at Sep. 30, 2021 |
|
|
38,605,096
|
|
|
|
|
|
|
|
Beginning balance at Mar. 31, 2021 |
236,537
|
|
$ 3,940
|
|
643,183
|
|
(410,266)
|
|
(320)
|
|
Beginning balance, shares at Mar. 31, 2021 |
|
|
38,271,641
|
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
1,904
|
|
$ 19
|
|
1,885
|
|
0
|
|
0
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
172,939
|
|
|
|
|
|
|
|
Stock-based compensation |
4,559
|
|
$ 0
|
|
4,559
|
|
0
|
|
0
|
|
Currency translation adjustment |
3,475
|
|
0
|
|
0
|
|
0
|
|
3,475
|
|
Net loss |
(27,388)
|
|
0
|
|
0
|
|
(27,388)
|
|
0
|
|
Ending balance at Jun. 30, 2021 |
219,087
|
|
$ 3,959
|
|
649,627
|
|
(437,654)
|
|
3,155
|
|
Ending balance, shares at Jun. 30, 2021 |
|
|
38,444,580
|
|
|
|
|
|
|
|
Exercise of stock options and vesting of restricted stock units |
2,313
|
|
$ 17
|
|
2,296
|
|
0
|
|
0
|
|
Exercise of stock options and vesting of restricted stock units, shares |
|
|
160,516
|
|
|
|
|
|
|
|
Short-swing profit disgorgement |
282
|
|
|
|
282
|
|
|
|
|
|
Stock-based compensation |
4,331
|
|
$ 0
|
|
4,331
|
|
0
|
|
0
|
|
Currency translation adjustment |
(5,391)
|
|
0
|
|
0
|
|
0
|
|
(5,391)
|
|
Net loss |
(14,853)
|
|
0
|
|
0
|
|
(14,853)
|
|
0
|
|
Ending balance at Sep. 30, 2021 |
$ 205,769
|
|
$ 3,976
|
|
$ 656,536
|
|
$ (452,507)
|
|
$ (2,236)
|
|
Ending balance, shares at Sep. 30, 2021 |
|
|
38,605,096
|
|
|
|
|
|
|
|